Today

Douglas Elliman registered 4.4 million additional shares for its employee incentive and stock purchase plans.

Energy Vault Holdings filed a universal shelf registration for $300 million, replacing an expiring shelf. This creates significant future offering capacity, representing 54.65% of the current market cap, but no immediate sales are planned.

The NYSE is delisting Farfetch's Class A ordinary shares and will suspend trading immediately due to the company's financial situation and plans to dispose of assets.

Lithium Argentina met its 2024 production goals and issued 2025 guidance, focusing on operational improvements and cost optimization.

Morphic Holding, Inc. has been acquired by Eli Lilly and Company's subsidiary, Rainier Acquisition Corporation, for $57.00 per share in cash, and will be delisted from Nasdaq.

FONAR Corp. has dismissed its auditor, Marcum LLP, and appointed CohnReznick LLP as its new independent registered public accounting firm.

Shattuck Labs announced a private placement of common stock and warrants, potentially raising up to $103 million, which will result in significant dilution for existing shareholders.

Abivax S.A. has completed a public offering of 10,156,000 ADSs, raising approximately $608.6 million, which introduces dilution risk for current shareholders.

Atlas Corp. plans to redeem its 7.125% Notes due 2027 and Series D and H Preferred Shares, and subsequently delist and deregister from the SEC.

Dada Nexus Limited has completed its going private transaction, with ADSs to be suspended from Nasdaq trading effective June 17, 2025.

Novo Nordisk announced a CEO transition and other executive leadership changes, effective August 7, 2025.

Novartis' Itvisma® gene therapy for spinal muscular atrophy (SMA) has received FDA approval for children two years and older, teens, and adults, marking a significant expansion of treatment access.

Novo Nordisk reported a 12% increase in net sales and a 5% increase in operating profit for 9M 2025, but narrowed its full-year guidance due to lower GLP-1 growth expectations and significant restructuring costs.

Nyxoah SA announced that the FDA issued an Approvable Letter for its Genio® system PMA, moving closer to U.S. market approval pending a manufacturing review.

Marathon Oil's common stock is delisted from the NYSE due to its acquisition by ConocoPhillips.

MSP Recovery, Inc.'s appeal against Nasdaq delisting was denied, resulting in the suspension of its common stock from trading on Nasdaq effective December 22, 2025.

Anebulo Pharmaceuticals will voluntarily delist its common stock from Nasdaq and deregister with the SEC, ending its public reporting obligations.

Twin Hospitality Group Inc. will be delisted from Nasdaq, with trading suspended on February 4, 2026, following its Chapter 11 bankruptcy filing.

JE Cleantech Holdings Ltd's 2025 net income surged to SGD3.2 million from SGD32 thousand, primarily due to a SGD4.1 million gain on asset disposition, while revenue grew 5.3% to SGD20.3 million.

POMDOCTOR Ltd's net loss widened by 250.4% to RMB130.9 million in FY2025, with operating cash flow deteriorating to negative RMB148.5 million, raising significant going concern doubts.